138 related articles for article (PubMed ID: 400932)
1. Infections due to endemic, multiply resistant gram-negative rods: sensitivity to and therapy with cefoxitin.
Alford RH
Rev Infect Dis; 1979; 1(1):175-82. PubMed ID: 400932
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial gram-negative bloodstream isolates: a comparison of in vitro antibiotic potency.
Stanley GL; Pfaller MA; Mori M; Wenzel RP
J Hosp Infect; 1989 Oct; 14(3):217-25. PubMed ID: 2575103
[TBL] [Abstract][Full Text] [Related]
3. Cefoxitin and cephamycins: microbiological studies.
Stapley EO; Birnbaum J; Miller AK; Wallick H; Hendlin D; Woodruff HB
Rev Infect Dis; 1979; 1(1):73-89. PubMed ID: 400941
[TBL] [Abstract][Full Text] [Related]
4. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
Schassan HH; Bentfeld G
Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility of gram-negative bacterial isolates to six beta-lactam and two aminoglycoside antibiotics at our university hospital].
Tanabe T; Kobayashi T; Yoshida S; Mizuguchi Y
J UOEH; 1988 Sep; 10(3):297-303. PubMed ID: 3175388
[TBL] [Abstract][Full Text] [Related]
6. Current status of therapy with cefoxitin.
McCloskey RV; Goren RC
Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
[TBL] [Abstract][Full Text] [Related]
7. Resistance patterns among nosocomial pathogens: trends over the past few years.
Jones RN
Chest; 2001 Feb; 119(2 Suppl):397S-404S. PubMed ID: 11171776
[TBL] [Abstract][Full Text] [Related]
8. Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.
Neu HC
Antimicrob Agents Chemother; 1974 Aug; 6(2):170-6. PubMed ID: 15828188
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the in vitro activity of cefoxitin and cephalothin against 7,312 clinical isolates.
Lingaas E; Midtvedt T; Melby K; Dahl OU
Chemotherapy; 1981; 27(4):239-46. PubMed ID: 7249786
[TBL] [Abstract][Full Text] [Related]
10. Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro.
Jackson RT; Thomas FE; Alford RH
Antimicrob Agents Chemother; 1977 Jan; 11(1):84-7. PubMed ID: 319753
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
Meyer RD
J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
[TBL] [Abstract][Full Text] [Related]
12. Use of cefoxitin sodium in difficult-to-treat infections.
Ramachandran Nair S; Cherubin CE
J Antimicrob Chemother; 1978 Jul; 4(B):167-78. PubMed ID: 357383
[No Abstract] [Full Text] [Related]
13. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
Une T; Mitsuhashi S
Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
15. Cefoxitin: an overview of clinical studies in the United States.
Neu HC
Rev Infect Dis; 1979; 1(1):233-9. PubMed ID: 400937
[TBL] [Abstract][Full Text] [Related]
16. Results of a clinical trial of cefoxitin, a new cephamycin antibiotic.
McCloskey RV
Antimicrob Agents Chemother; 1977 Nov; 12(5):636-41. PubMed ID: 335968
[TBL] [Abstract][Full Text] [Related]
17. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
[TBL] [Abstract][Full Text] [Related]
18. Cefoxitin resistance in community-acquired gram-negative bacillary bacteremia. Associated clinical risk factors.
McCue JD
Arch Intern Med; 1985 May; 145(5):834-6. PubMed ID: 3873228
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin.
Moellering RC; Dray M; Kunz LJ
Antimicrob Agents Chemother; 1974 Sep; 6(3):320-3. PubMed ID: 15830480
[TBL] [Abstract][Full Text] [Related]
20. Cefoxitin sodium therapy of anaerobic infections.
Busch DF; Heseltine PN; Meyer RD; Sutter VL; Finegold SM
J Antimicrob Chemother; 1978 Jul; 4(B):197-202. PubMed ID: 357386
[No Abstract] [Full Text] [Related]
[Next] [New Search]
